Genocea Biosciences (Cambridge, MA), a clinical-stage biotechnology company focused on therapeutic and prophylactic vaccines for infectious diseases, closed a $30M Series C financing. Participants include Bill & Melinda Gates Foundation, Central Valley Fund, Johnson & Johnson Development Corp., Skyline Ventures, MP Healthcare Venture Management, Polaris Venture Partners, Lux Capital Management, SR One, Cycad Group, Auriga Partners and Morningside Ventures.

Collective IP | The Most Comprehensive and Accurate View of Global Innovation and Organization of the International Technology Transfer Office Ecosystem

Request Collective IP Account Access HERE